New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
July 1, 2014
10:01 EDTIGTE, NFLX, ENH, SCOR, NBR, FOLD, YRCW, HEESOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Amicus Therapeutics (FOLD) upgraded to Buy from Neutral at Janney Capital... Endurance Specialty (ENH) upgraded to Buy from Neutral at BofA/Merrill... H&E Equipment (HEES) upgraded at KeyBanc... Nabors Industries (NBR) upgraded to Overweight from Equal Weight at Stephens... Netflix (NFLX) upgraded at Goldman... YRC Worldwide (YRCW) upgraded to Peer Perform from Underperform at Wolfe Research... comScore (SCOR) upgraded to Buy from Neutral at Goldman... iGATE (IGTE) upgraded to Buy from Hold at Jefferies.
News For FOLD;ENH;HEES;NBR;NFLX;YRCW;SCOR;IGTE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | all recent news | >>
March 19, 2015
16:01 EDTNFLXOptions Update; March 19, 2015
Subscribe for More Information
11:02 EDTNFLXOptions with increasing implied volatility
Options with increasing implied volatility: HLF RAD NFLX HLSS NOW
10:42 EDTFOLDOptions with decreasing implied volatility
Subscribe for More Information
10:23 EDTFOLDHigh option volume stocks
Subscribe for More Information
09:37 EDTFOLD, NFLXActive equity options trading on open
Subscribe for More Information
09:20 EDTFOLDOn The Fly: Pre-market Movers
Subscribe for More Information
08:20 EDTFOLDAmicus to host conference call
Subscribe for More Information
07:59 EDTFOLDAmicus NDA submission removes key overhang, says JPMorgan
Subscribe for More Information
06:07 EDTFOLDAmicus reports positive results in meetings with EMA and FDA
Amicus has met with regulatory authorities in Europe and the U.S. to discuss the approval pathways for the oral small molecule pharmacological chaperone migalastat HCl as a precision medicine monotherapy for Fabry patients who have amenable genetic mutations. The company held a meeting with the assigned European Rapporteurs to discuss the upcoming marketing authorization application for migalastat monotherapy. The Rapporteurs agreed that Amicus may submit its MAA for migalastat monotherapy under the Full Approval pathway in the EU and indicated support for Amicus to request Accelerated Assessment. Amicus is accelerating the timing of the MAA submission for full approval for migalastat monotherapy from the middle of 2015 to Q2. Amicus held a Type C meeting with the FDA and plans to submit an NDA for Accelerated Approval, for which the FDA is open to considering several potential surrogate endpoints evaluated in the clinical studies of migalastat. Amicus plans to schedule a pre-NDA meeting and to submit an NDA under Subpart H in 2H15
05:57 EDTNFLXStocks with implied volatility above IV index mean; BBRY NFLX
Subscribe for More Information
March 18, 2015
13:23 EDTNFLXBattleground: Oppenheimer weighs in on Netflix with positive note
The recent weakness in Netflix's (NFLX) stock has created a buying opportunity, Oppenheimer wrote in a note to investors today. Oppenheimer's upbeat note comes after research firm Stifel issued a positive note on the stock yesterday and a third firm, Evercore ISI, downgraded the shares to sell on Monday. BULLISH TAKE: Noting that Netflix's stock has dropped 15% from its 52-week high, Oppenheimer analyst Jason Helfstein said that the decline creates a good buying opportunity ahead a number of "tier 1" original show launches by the company. History indicates that tier 1 original shows have the most impact on the company's net subscriber additions, the analyst stated. Worries about competition have weighed on the shares, but Netflix can beat the competition by using its data to provide superior programming, according to the analyst. He kept a $483 price target and Outperform rating on the shares. Stifel analyst Scott Devitt yesterday stated that concerns about the company's competition are overdone, as Netflix's positioning in the U.S. is as strong as ever and continues to improve as it adds more content. Time Warner's (TWX) upcoming launch of a video on demand service called HBO Now is the primary cause of the decline in Netflix's stock, Devitt contended, noting he views the HBO Now launch as "a non-event" for Netflix. Most Netflix subscribers who obtain HBO Now will probably keep both services, Devitt believes. BEARISH TAKE: Evercore ISI analyst Ken Sena on Monday downgraded Netflix shares to Sell from Hold. Increased competition will force the company to raise its investments, and the return from those investments is uncertain, the analyst contended. In the U.S., technological advancements are enabling content providers to sell their programming to a wider range of Internet video distributors. Moreover, content providers themselves are now able to stream more of their programming online and obtain higher profits from doing so, Sena reported. Netflix's international expansion will not be sufficient to offset the increased competition, especially because foreign viewers are likely to watch less TV and be less interested in paying for TV content, the analyst believes, adding that Netflix will face even more competition overseas than in the U.S. Sela reduced his price target on the shares to $380 from $450. PRICE ACTION: In mid-afternoon trading, Netflix was little changed near $418 per share.
08:05 EDTNFLXNetflix weakness creates buying opportunity, says Oppenheimer
Subscribe for More Information
06:01 EDTNFLXStocks with implied volatility above IV index mean; BBRY NFLX
Subscribe for More Information
March 17, 2015
16:00 EDTNFLXOptions Update; March 17, 2015
iPath S&P 500 VIX Short-Term Futures down 11c to 27.30. Option volume leaders: AAPL RIG MGM HTZ TWTR TSLA CY KO NFLX C according to Track Data.
13:06 EDTNFLXBattleground: Analysts take opposite sides on Netflix
Subscribe for More Information
11:23 EDTNFLXApple willing to share TV data to attract programming partners, NY Post reports
Subscribe for More Information
10:26 EDTFOLD, NFLXOptions with increasing implied volatility
Subscribe for More Information
09:34 EDTNFLXActive equity options trading on open
Subscribe for More Information
07:12 EDTNFLXConcerns over Netflix competition overblown, says Stifel
Subscribe for More Information
05:50 EDTNFLXStocks with implied volatility movement; DD NFLX
Subscribe for More Information
1 | 2 | 3 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use